​

Organogenesis (ORGO) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Organogenesis Revenue Highlights

Latest Revenue (Y)

$433.14M

Latest Revenue (Q)

$115.18M

Main Segment (Y)

Advanced Wound care

Organogenesis Revenue by Period

Organogenesis Revenue by Year

DateRevenueChange
2023-12-31$433.14M-3.94%
2022-12-31$450.89M-3.67%
2021-12-31$468.06M38.36%
2020-12-31$338.30M29.63%
2019-12-31$260.98M34.91%
2018-12-31$193.45M100.00%
2017-12-31-100.00%
2016-12-31--

Organogenesis generated $433.14M in revenue during NA 2023, up -3.94% compared to the previous quarter, and up 223.90% compared to the same period a year ago.

Organogenesis Revenue by Quarter

DateRevenueChange
2024-09-30$115.18M-11.56%
2024-06-30$130.23M18.42%
2024-03-31$109.98M10.36%
2023-12-31$99.65M-8.18%
2023-09-30$108.53M-7.49%
2023-06-30$117.32M8.99%
2023-03-31$107.64M-6.82%
2022-12-31$115.52M-1.15%
2022-09-30$116.86M-3.74%
2022-06-30$121.40M23.73%
2022-03-31$98.12M-23.68%
2021-12-31$128.56M13.02%
2021-09-30$113.75M-7.67%
2021-06-30$123.20M20.13%
2021-03-31$102.55M-3.98%
2020-12-31$106.81M5.96%
2020-09-30$100.80M46.17%
2020-06-30$68.96M11.71%
2020-03-31$61.73M-17.30%
2019-12-31$74.64M16.15%
2019-09-30$64.27M-1.05%
2019-06-30$64.95M13.70%
2019-03-31$57.12M-10.18%
2018-12-31$63.60M100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31--100.00%
2017-12-31$6.59M100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31--100.00%
2016-12-31$61.08K100.00%
2016-09-30-100.00%
2016-06-30-100.00%
2016-03-31--

Organogenesis generated $115.18M in revenue during Q3 2024, up -11.56% compared to the previous quarter, and up 98.18% compared to the same period a year ago.

Organogenesis Revenue Breakdown

Organogenesis Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
Advanced Wound care$405.51M$422.23M$430.84M$294.62M$220.74M
Surgical and Sports Medicine$27.63M$28.66M$37.22M$43.67M$40.24M

Organogenesis's latest annual revenue breakdown by segment (product or service), as of Dec 23: Advanced Wound care (93.62%), and Surgical and Sports Medicine (6.38%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Surgical and Sports Medicine$7.22M$6.11M$6.49M$7.17M$7.24M$6.72M$6.68M$7.34M$7.61M$7.17M$7.20M$6.41M$11.76M$11.84M$13.19M$10.81M$9.23M$10.44M$11.27M$9.96M
Advanced Wound care$107.95M$103.86M$93.17M$101.36M$110.08M$100.92M$108.84M$109.51M$113.79M$90.95M$121.35M$107.34M$111.44M$90.71M$93.61M$89.99M$59.73M$51.29M$63.38M$54.31M

Organogenesis's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Advanced Wound care (93.73%), and Surgical and Sports Medicine (6.27%).

Organogenesis Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
PTPIPetros Pharmaceuticals$5.82B$1.42M
NBIXNeurocrine Biosciences$1.89B$622.10M
ALKSAlkermes$1.66B$378.14M
COLLCollegium Pharmaceutical$566.77M$159.30M
ITCIIntra-Cellular Therapies$462.18M$175.38M
ORGOOrganogenesis$433.14M$115.18M
DVAXDynavax$232.28M$79.34M
LFCRLifecore Biomedical$128.26M$24.70M
TKNOAlpha Teknova$36.68M$9.58M
RDHLRedHill Biopharma$6.51M$1.80M
SHPHShuttle Pharmaceuticals--

ORGO Revenue FAQ

What is Organogenesis’s yearly revenue?

Organogenesis's yearly revenue for 2023 was $433.14M, representing a decrease of -3.94% compared to 2022. The company's yearly revenue for 2022 was $450.89M, representing a decrease of -3.67% compared to 2021. ORGO's yearly revenue for 2021 was $468.06M, representing an increase of 38.36% compared to 2020.

What is Organogenesis’s quarterly revenue?

Organogenesis's quarterly revenue for Q3 2024 was $115.18M, a -11.56% decrease from the previous quarter (Q2 2024), and a 6.12% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $130.23M, a 18.42% increase from the previous quarter (Q1 2024), and a 11.01% increase year-over-year (Q2 2023). ORGO's quarterly revenue for Q1 2024 was $109.98M, a 10.36% increase from the previous quarter (Q4 2023), and a 2.17% increase year-over-year (Q1 2023).

What is Organogenesis’s revenue growth rate?

Organogenesis's revenue growth rate for the last 3 years (2021-2023) was -7.46%, and for the last 5 years (2019-2023) was 65.97%.

What are Organogenesis’s revenue streams?

Organogenesis's revenue streams in c 23 are Advanced Wound care, and Surgical and Sports Medicine. Advanced Wound care generated $405.51M in revenue, accounting 93.62% of the company's total revenue, down -3.96% year-over-year. Surgical and Sports Medicine generated $27.63M in revenue, accounting 6.38% of the company's total revenue, down -3.61% year-over-year.

What is Organogenesis’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Organogenesis was Advanced Wound care. This segment made a revenue of $405.51M, representing 93.62% of the company's total revenue.